GenMark Diagnostics (GNMK) Tops Q3 EPS by 4c

November 4, 2016 8:10 AM EDT
Get Alerts GNMK Hot Sheet
Trade GNMK Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

GenMark Diagnostics (NASDAQ: GNMK) reported Q3 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $10.8 million versus the consensus estimate of $10.36 million.

GUIDANCE:

GenMark Diagnostics sees FY2016 revenue of $47-51 million, versus the consensus of $49.0 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment